Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PACTAID App in Adults With Type 1 Diabetes to Help Manage Exercise

NCT: NCT06730906 · ENROLLING_BY_INVITATION

NCT IDNCT06730906
StatusENROLLING_BY_INVITATION
Start Date2025-01-10
Completion2026-12-31
SponsorMayo Clinic (OTHER)
First posted
Last updated

Brief Summary

The purpose of this trial is to test and refine the PACTAID smart phone application in adults with type 1 diabetes mellitus to help manage exercise while on automated insulin delivery systems with the goal of improving glycemic control during and after exercise as well as improving multiple other cardiovascular risk factors.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑